Td Asset Management Inc Fate Therapeutics Inc Transaction History

Td Asset Management Inc

$107 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$3.54 - $8.35 $88,500 - $208,750	25,000 New	25,000 $183,000
Q3 2023 Oct 27, 2023	BUY	$2.02 - $5.04 $143,068 - $356,963	70,826 Added 100.0%	141,652 $300,000
Q4 2022 Feb 06, 2023	SELL	$9.86 - $23.83 $184,382 - $445,620	-18,700 Reduced 20.89%	70,826 $714,000
Q3 2022 Nov 07, 2022	SELL	$21.04 - $36.06 $477,902 - $819,066	-22,714 Reduced 20.24%	89,526 $2 Million
Q2 2022 Aug 04, 2022	SELL	$17.78 - $42.39 $94,945 - $226,362	-5,340 Reduced 4.54%	112,240 $2.78 Million
Q1 2022 May 10, 2022	BUY	$29.67 - $60.28 $323,373 - $656,991	10,899 Added 10.22%	117,580 $4.56 Million
Q3 2021 Nov 09, 2021	BUY	$59.27 - $95.73 $1.12 Million - $1.81 Million	18,871 Added 21.49%	106,681 $6.32 Million
Q2 2021 Aug 11, 2021	SELL	$67.25 - $92.52 $53,800 - $74,016	-800 Reduced 0.9%	87,810 $7.27 Million
Q1 2021 May 14, 2021	SELL	$72.16 - $117.4 $41,131 - $66,918	-570 Reduced 0.64%	88,610 $7.31 Million
Q4 2020 Feb 16, 2021	BUY	$38.09 - $100.95 $1.17 Million - $3.1 Million	30,700 Added 52.5%	89,180 $8.11 Million
Q3 2020 Nov 10, 2020	BUY	$30.41 - $40.5 $732,881 - $976,050	24,100 Added 70.1%	58,480 $2.34 Million
Q2 2020 Aug 13, 2020	BUY	$20.21 - $35.23 $66,106 - $115,237	3,271 Added 10.51%	34,380 $1.18 Million
Q1 2020 May 15, 2020	SELL	$17.28 - $31.88 $67,392 - $124,332	-3,900 Reduced 11.14%	31,109 $691,000
Q4 2019 Feb 11, 2020	SELL	$13.39 - $20.73 $95,069 - $147,183	-7,100 Reduced 16.86%	35,009 $685,000
Q3 2019 Nov 07, 2019	BUY	$15.47 - $22.5 $3,094 - $4,500	200 Added 0.48%	42,109 $654,000
Q2 2019 Aug 01, 2019	BUY	$15.61 - $20.44 $26,537 - $34,748	1,700 Added 4.23%	41,909 $851,000
Q1 2019 May 08, 2019	SELL	$13.15 - $18.71 $52,600 - $74,840	-4,000 Reduced 9.05%	40,209 $706,000
Q4 2018 Feb 01, 2019	BUY	$11.48 - $16.98 $34,715 - $51,347	3,024 Added 7.34%	44,209 $567,000
Q3 2018 Nov 01, 2018	BUY	$8.75 - $16.29 $50,618 - $94,237	5,785 Added 16.34%	41,185 $671,000
Q2 2018 Jul 31, 2018	SELL	$9.16 - $13.48 $56,792 - $83,576	-6,200 Reduced 14.9%	35,400 $401,000
Q1 2018 May 11, 2018	BUY	$6.3 - $13.77 $144,471 - $315,773	22,932 Added 122.84%	41,600 $406,000
Q4 2017 Feb 02, 2018	BUY	$3.94 - $6.64 $73,551 - $123,955	18,668	18,668 $114,000

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

Redmile Group, LLC San Francisco, CA

13.2M
Shares

$21.9 Million
3.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.4M
Shares

$17.3 Million
0.0% of portfolio
Black Rock Inc. New York, NY

10.1M
Shares

$16.8 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

5.57M
Shares

$9.25 Million
0.72% of portfolio
State Street Corp Boston, MA

5.25M
Shares

$8.72 Million
0.0% of portfolio

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $161M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account